Medical And Diagnostic Laboratory Services Market Report 2026

Medical And Diagnostic Laboratory Services Market Overview

• Medical And Diagnostic Laboratory Services market size has reached to $212.41 billion in 2025

• Expected to grow to $314.61 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%

• Growth Driver: The Role Of Medical Laboratories In Tackling Lifestyle-Related Diseases

• Market Trend: Emerging Digital And Molecular Innovations Reshaping Diagnostic Laboratory Efficiency

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical And Diagnostic Laboratory Services Market?

Medical and diagnostic laboratory services are services that provide diagnostic tests for various diseases. The tests are used to detect if the person has encountered the disease. Medical and diagnostic laboratory services make it possible to deliver prompt, affordable, and high-quality diagnostic services in secure settings.

The main types of medical and diagnostic laboratory services are diagnostic imaging centers and medical laboratory services. A diagnostic imaging center is a service provider that offers technical or comprehensive diagnostic imaging services. The different expenditure types include public and private which are used in various applications such as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others. The services are used by males and females.

What Is The Medical And Diagnostic Laboratory Services Market Size and Share 2026?

The medical and diagnostic laboratory services market size has grown strongly in recent years. It will grow from $212.41 billion in 2025 to $229.3 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growth in disease burden, increasing physician reliance on diagnostics, expansion of hospital infrastructure, rising healthcare awareness, improved access to basic diagnostic testing.

Global Medical And Diagnostic Laboratory Services Market Segmentation

1) By Type: Diagnostic Imaging Centers, Medical Laboratory Services

2) By Type of Expenditure: Public, Private

3) By Application: Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications

4) By End User Gender: Male, Female

Subsegments:

1) By Diagnostic Imaging Centers: X-ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Computed Tomography (CT) Scans, Nuclear Imaging, Mammography

2) By Medical Laboratory Services: Clinical Chemistry, Hematology, Microbiology, Immunology/Serology, Molecular Diagnostics, Pathology, Blood Banking/Transfusion Services

What Are The Drivers Of The Medical And Diagnostic Laboratory Services Market?

The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. For instance, in July 2023, according to the Office for National Statistics, a UK-based department, in the first quarter of 2023, over 1.35 million individuals (53%) who were inactive due to long-term illness reported experiencing depression, anxiety, or nervousness. Tests to diagnose these diseases include HbA1c tests for monitoring diabetes, biopsies, tumor marker tests, bone scans, MRI and CT scans for diagnosis of various cancers, electrocardiograms, chest X-rays, cardiac CT scans, and stress tests for detection of cardiovascular diseases. The increase in the prevalence of lifestyle diseases will increase the demand for tests to diagnose these diseases and thus will drive the medical and diagnostic laboratory services industry during the forecast period.

The rising geriatric population is expected to propel the growth of the medical and diagnostic laboratory services market going forward. The geriatric population is the segment of the population that consists of older adults, typically defined as individuals who are 65 or older. Medical and diagnostic laboratory services for the geriatric population play a vital role in early disease detection and monitoring, facilitating timely interventions, and improving overall health outcomes in elderly individuals. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million individuals aged 65 or older in the UK, making up 19% of the total population. By 2072, this number is expected to increase to 22.1 million, comprising 27% of the population. Therefore, the rising geriatric population is driving the growth of the medical and diagnostic laboratory services industry.

Key Players In The Global Medical And Diagnostic Laboratory Services Market

Major companies operating in the medical and diagnostic laboratory services market are Laboratory Corporation of America, Eurofins Scientific, Quest Diagnostics Incorporated, Sonic Healthcare Limited, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories Inc., NeoGenomics Laboratories Inc., Bio-Reference Laboratories Inc., Guardant Health Inc., Invitae Corporation, Natera Inc., Foundation Medicine Inc., Veracyte Inc., Exact Sciences Corporation, Fulgent Genetics Inc., Progenity Inc., Adaptive Biotechnologies Corporation, Biocept Inc., Interpace Biosciences Inc., Psychemedics Corporation, Aeon Global Health Corp., Avellino Labs USA Inc., Bio-Techne Corporation, Enzo Clinical Labs Inc., Genoptix Inc., Genova Diagnostics Inc.

Global Medical And Diagnostic Laboratory Services Market Trends and Insights

Major companies operating in the medical and diagnostic laboratory services market are focusing on developing innovative solutions, such as enterprise molecular-diagnostics workflow software, to meet the rising demand for faster, higher-throughput qPCR testing, greater assay standardization, regulatory traceability, and improved lab efficiency driven by public-health surveillance and expanding molecular test menus. Enterprise molecular-diagnostics workflow software is a unified, on-premise/integrated platform that connects instruments, assays, sample and reagent tracking, automated quality-control and data interpretation, and laboratory information systems (LIS) in a single interface. For instance, in July 2023, Thermo Fisher Scientific, a US-based life-sciences company, launched Diomni Enterprise Software, an enterprise qPCR/molecular diagnostics workflow platform. Diomni is built as a scalable, on-premise software suite that links sample tracking, instrument control and result reporting into one ecosystem; it supports assay development files (ADF) and routine qPCR workflows, automates QC and fluorescence-curve interpretation, and integrates with LIS for audit trails and 21 CFR Part 11–style controls. Unique features include customizable, lockable assay templates, concurrent multi-user access, automated reagent and sample traceability, and built-in compliance/audit functionality benefits that translate to reduced manual steps, improved reproducibility, and up to multi-hour reductions in qPCR time-to-results reported by early adopters.

Regional Outlook

North America was the largest region in the medical and diagnostic laboratory services market in 2025. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Medical And Diagnostic Laboratory Services Market?

The medical and diagnostic laboratory services market includes revenues earned by entities by providing diagnostic services such as diagnostic laboratory services, X-ray, CT scan, and Mammography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medical And Diagnostic Laboratory Services Market Report 2026?

The medical and diagnostic laboratory services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical and diagnostic laboratory services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.